World's Best Scientists 2026 revealed!

D-Index & Metrics

Genetics

D-Index
78
Citations
32035
World Ranking
1673
National Ranking
218

Janet Shipley publication distribution in Genetics in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Genetics in 2026. The highlighted bar marks where Janet Shipley sits on this spectrum.

45–54 publications: 6 scientists 55–64 publications: 10 scientists 65–74 publications: 35 scientists 75–84 publications: 84 scientists 85–94 publications: 102 scientists 95–104 publications: 151 scientists 105–114 publications: 175 scientists 115–124 publications: 203 scientists 125–134 publications: 217 scientists 135–144 publications: 205 scientists 145–154 publications: 193 scientists 155–164 publications: 188 scientists 165–174 publications: 170 scientists 175–184 publications: 178 scientists 185–194 publications: 164 scientists 195–204 publications: 173 scientists 205–214 publications: 159 scientists 215–224 publications: 134 scientists 225–234 publications: 143 scientists 235–244 publications: 105 scientists 245–254 publications: 114 scientists 255–264 publications: 92 scientists 265–274 publications: 88 scientists 275–284 publications: 87 scientists 285–294 publications: 80 scientists 295–304 publications: 62 scientists 305–314 publications: 75 scientists 315–324 publications: 67 scientists 325–334 publications: 60 scientists 335–344 publications: 52 scientists 345–354 publications: 40 scientists 355–364 publications: 48 scientists 365–374 publications: 47 scientists 375–384 publications: 46 scientists 385–394 publications: 31 scientists 395–404 publications: 27 scientists 405–414 publications: 40 scientists 415–424 publications: 30 scientists 425–434 publications: 43 scientists 435–444 publications: 29 scientists 445–454 publications: 14 scientists 455–464 publications: 28 scientists 465–474 publications: 21 scientists 475–484 publications: 21 scientists 485–494 publications: 22 scientists 495–504 publications: 17 scientists 505–514 publications: 12 scientists 515–524 publications: 11 scientists 525–534 publications: 8 scientists 535–544 publications: 8 scientists 545–554 publications: 14 scientists 555–564 publications: 4 scientists 565–574 publications: 11 scientists 575–584 publications: 5 scientists 585–594 publications: 11 scientists 595–604 publications: 12 scientists 605–614 publications: 7 scientists 615–624 publications: 6 scientists 625–634 publications: 10 scientists 635–644 publications: 9 scientists 645–654 publications: 10 scientists 655–664 publications: 6 scientists 665–674 publications: 6 scientists 675–684 publications: 6 scientists 685–694 publications: 4 scientists 695–702 publications: 6 scientists 703+ publications: 100 scientists
45 publications 703+

This scientist: 244 publications — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 703 publications or more.

Janet Shipley D-index placement in Genetics in 2026

The chart shows the D-index (discipline H-index) distribution of Genetics scientists ranked by Research.com in 2026. The highlighted bar marks where Janet Shipley sits on this spectrum.

40–41 D-Index: 24 scientists 42–43 D-Index: 52 scientists 44–45 D-Index: 84 scientists 46–47 D-Index: 112 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 141 scientists 52–53 D-Index: 143 scientists 54–55 D-Index: 145 scientists 56–57 D-Index: 179 scientists 58–59 D-Index: 162 scientists 60–61 D-Index: 175 scientists 62–63 D-Index: 191 scientists 64–65 D-Index: 172 scientists 66–67 D-Index: 184 scientists 68–69 D-Index: 164 scientists 70–71 D-Index: 158 scientists 72–73 D-Index: 150 scientists 74–75 D-Index: 136 scientists 76–77 D-Index: 127 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 111 scientists 82–83 D-Index: 110 scientists 84–85 D-Index: 110 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 102 scientists 90–91 D-Index: 66 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 70 scientists 96–97 D-Index: 54 scientists 98–99 D-Index: 60 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 55 scientists 104–105 D-Index: 45 scientists 106–107 D-Index: 42 scientists 108–109 D-Index: 28 scientists 110–111 D-Index: 39 scientists 112–113 D-Index: 25 scientists 114–115 D-Index: 31 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 34 scientists 120–121 D-Index: 29 scientists 122–123 D-Index: 29 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 27 scientists 128–129 D-Index: 22 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 11 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 21 scientists 140–141 D-Index: 4 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 14 scientists 146–147 D-Index: 6 scientists 148–149 D-Index: 10 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 9 scientists 154–155 D-Index: 8 scientists 156–157 D-Index: 8 scientists 158–159 D-Index: 9 scientists 160+ D-Index: 96 scientists
40 D-Index 160+

This scientist: 78 D-Index — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 160 D-Index or more.

Overview

Janet Shipley is affiliated with the Institute of Cancer Research in the United Kingdom and has a research profile focused on oncology, molecular biology, and cancer diagnostics. Their work spans medicine and biochemistry, genetics, and molecular biology, with notable contributions to pulmonary and respiratory medicine as well as pathology and forensic medicine.

Their research covers several specialized subfields including oncology, cancer research, sarcoma diagnosis and treatment, and protein degradation and inhibitors. Specific main topics include:

  • Sarcoma Diagnosis and Treatment
  • Tumors and Oncological Cases
  • CAR-T Cell Therapy Research
  • Protein Degradation and Inhibitors
  • Cancer Genomics and Diagnostics
  • Lymphoma Diagnosis and Treatment
  • Bone Tumor Diagnosis and Treatments

Janet Shipley collaborates frequently with several coauthors, reflecting continued partnerships in cancer research:

  • Anna Kelsey
  • Susanne A. Gatz
  • Julia Chisholm
  • Joanna Selfe
  • Meriel Jenney

Their scholarly output is regularly published in journals with a strong focus on cancer and molecular research. Frequent publication venues include:

  • Cancers
  • Cancer Research
  • Pediatric Blood & Cancer
  • European Journal of Cancer
  • Nature Communications

Several recent papers authored or coauthored by Shipley highlight areas of genomic classification, risk stratification, and molecular testing in oncology, particularly focusing on sarcomas and testicular cancers. These include:

  • "Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium" (2021) published in Journal of Clinical Oncology
  • "Pathology of childhood rhabdomyosarcoma: A consensus opinion document from the Children's Oncology Group, European Paediatric Soft Tissue Sarcoma Study Group, and the Cooperative Weichteilsarkom Studiengruppe" (2020) published in Pediatric Blood & Cancer
  • "Genomic landscape of platinum resistant and sensitive testicular cancers" (2020) published in Nature Communications
  • "Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe" (2022) published in European Journal of Cancer
  • "Germline and Somatic Genetic Variants in the p53 Pathway Interact to Affect Cancer Risk, Progression, and Drug Response" (2021) published in Cancer Research

Best Publications

  • Mutations of the BRAF gene in human cancer

    Helen Davies;Graham R. Bignell;Charles Cox;Philip Stephens

  • Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma

    J Clark;P J Rocques;A J Crew;S Gill

  • A census of amplified and overexpressed human cancer genes

    Thomas Santarius;Janet Shipley;Daniel Brewer;Michael R. Stratton

  • Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma.

    A.J. Crew;J. Clark;C. Fisher;S. Gill

  • Fusion Gene-Negative Alveolar Rhabdomyosarcoma Is Clinically and Molecularly Indistinguishable From Embryonal Rhabdomyosarcoma

    Daniel Williamson;Edoardo Missiaglia;Aurélien de Reyniès;Gaëlle Pierron

  • Testicular germ-cell cancer

    Alan Horwich;Janet Shipley;Robert Huddart

  • Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinoma.

    J Clark;YJ Lu;SK Sidhar;C Parker

  • PAX3/FOXO1 Fusion Gene Status Is the Key Prognostic Molecular Marker in Rhabdomyosarcoma and Significantly Improves Current Risk Stratification

    Edoardo Missiaglia;Dan Williamson;Julia Chisholm;Pratyaksha Wirapati

  • The t(X;1)(p11.2;q21.2) Translocation in Papillary Renal Cell Carcinoma Fuses a Novel Gene PRCC to the TFE3 Transcription Factor Gene

    SK Sidhar;J Clark;S Gill;RA Hamoudi

  • Poorly differentiated synovial sarcoma: an analysis of clinical, pathologic, and molecular genetic features.

    van de Rijn M;Barr Fg;Xiong Qb;Hedges M

  • Fusion of the EWS gene to CHN, a member of the steroid/thyroid receptor gene superfamily, in a human myxoid chondrosarcoma.

    J. Clark;H. Benjamin;S. Gill;Sanjiu Sidhar

  • Genomic and expression profiling of human spermatocytic seminomas: primary spermatocyte as tumorigenic precursor and DMRT1 as candidate chromosome 9 gene.

    Leendert H.J. Looijenga;Remko Hersmus;Ad J.M. Gillis;Rolph Pfundt

  • Gains, Losses, and Amplification of Genomic Material in Rhabdomyosarcoma Analyzed by Comparative Genomic Hybridization

    Stephen Weber-Hall;John Anderson;Aidan McManus;Syuiti Abe

  • Genes, chromosomes, and rhabdomyosarcoma

    John Anderson;Anthony Gordon;Kathy Pritchard-Jones;Janet Shipley

  • Comparative genomic hybridization analysis of lobular carcinoma in situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic material in breast neoplasia

    Yong-Jie Lu;Pinchas Osin;Sunil R. Lakhani;Silvana Di Palma

  • The SYT Protein Involved in the t(X;18) Synovial Sarcoma Translocation is a Transcriptional Activator Localised in Nuclear Bodies

    David Brett;Suzanna Whitehouse;Per Antonson;Janet Shipley

  • Whole-exome sequencing reveals the mutational spectrum of testicular germ cell tumours

    Kevin Litchfield;Brenda Summersgill;Shawn E Yost;Razvan Sultana

  • Gain of 1q Is Associated with Adverse Outcome in Favorable Histology Wilms’ Tumors

    Sandra Hing;Yong-Jie Lu;Brenda Summersgill;Linda King-Underwood

  • Amplification and Overexpression of the KIT Gene Is Associated with Progression in the Seminoma Subtype of Testicular Germ Cell Tumors of Adolescents and Adults

    Alan McIntyre;Brenda Summersgill;Beata Grygalewicz;Ad J.M. Gillis

  • EPIGENETICS AND GENETICS A census of amplified and overexpressed human cancer genes

    T Santarius;J Shipley;D Brewer;M. R Stratton

Frequent Co-Authors

Kathy Pritchard-Jones
Kathy Pritchard-Jones University College London
Robert Huddart
Robert Huddart Institute of Cancer Research
Cyril Fisher
Cyril Fisher Royal Marsden NHS Foundation Trust
Olivier Delattre
Olivier Delattre PSL University
Colin Cooper
Colin Cooper University of East Anglia
Richard S. Houlston
Richard S. Houlston Institute of Cancer Research
Clare Turnbull
Clare Turnbull Institute of Cancer Research
Gilles Vassal
Gilles Vassal Institut Gustave Roussy
Rogier Versteeg
Rogier Versteeg University of Amsterdam
Torsten Pietsch
Torsten Pietsch University of Bonn

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Genetics in the USA opens doors to diverse online degrees and career options. Many students opt for health-related fields like bioinformatics, lab technology, or medical administration. For those interested in administration, consider accredited medical billing and coding schools with financial aid, which combine healthcare knowledge with practical skills for entry-level roles.

Flexibility is essential for today’s learners. Enrolling in fast track programs allows students to earn qualifications sooner and pivot to new opportunities in genetics or related fields more quickly. Alternatively, self paced online college programs offer convenience, letting you balance studies with personal or work commitments.

For those starting their journey, finding free application online colleges can remove barriers and minimize upfront costs. All these pathways help build a strong foundation for genetics-related careers or further education in the life sciences.

Best Scientists Citing Janet Shipley

Trending Scientists

Recently Published Articles